Neurofeedback Therapy

Brain-training therapy guided by qEEG data to retrain unhelpful brainwave patterns linked to poor sleep, anxiety, stress, and cognitive difficulties. Protocols are personalised to each client's brain map results and delivered by the clinic's brain specialist.

Neurofeedback therapy at New Leaf is a non-invasive, evidence-informed brain training modality that teaches the brain to self-regulate its electrical activity more effectively. It is delivered by Santiago Brand, the clinic's brain specialist, and is always preceded by a qEEG Brain Mapping assessment, which provides the personalised protocol guiding each client's treatment plan. During a neurofeedback session, EEG sensors placed on the scalp feed real-time brainwave data into specialist software. The client watches a visual display — often a video or interactive game — that responds to their brain activity: when the brain produces the desired wave patterns, the display rewards them with positive feedback (the video plays smoothly, the game progresses). When the brain drifts into dysregulated patterns, the feedback subtly signals this, prompting the brain to self-correct. Over multiple sessions, this operant conditioning process gradually trains the brain toward more regulated, adaptive activity patterns. Sleep disturbances are one of the primary applications of neurofeedback at New Leaf. Dysregulated slow-wave delta activity, excessive high-frequency beta during sleep onset, or disrupted theta transitions are common neurological patterns in people with insomnia and non-restorative sleep. Personalised neurofeedback protocols targeting these specific dysregulations can help normalise sleep architecture and reduce the time it takes to fall and stay asleep, without the dependency risks associated with sleep medication. Beyond sleep, neurofeedback at New Leaf is applied to anxiety, attention difficulties, PTSD, and cognitive fatigue — all conditions that share underlying patterns of neurological dysregulation. The number of sessions required varies by individual and condition; the brain mapping assessment provides the starting point for estimating a typical protocol length and discussing expected outcomes.